Many COVID-19 diagnostics programs have been delayed or derailed because of unanticipated challenges. COVID-19 success will require overcoming a variety of obstacles, from assay design and regulatory hurdles to sample sourcing and reimbursement considerations. This webinar will explore real-world examples that will help you anticipate pitfalls, mitigate risk and accelerate development.

Register to learn the valuable insights Precision has gained from participation in multiple COVID-19 research studies to understand the contingencies for success and, just as critical, to anticipate pitfalls that can be avoided.

Understand how to:

Build a biospecimen foundation for diagnostic development Navigate the regulatory landscape for serology tests, from EUA to 510(k) Leverage important design considerations for market access Recommended for: Biotech R&D teams developing COVID-19 antibody tests Clinical operations specialists managing studies for 510(k) submission Regulatory affairs teams working on EUAs or formal submissions to the FDA Procurement specialists looking to identify appropriate specimens for their research Register Now!